M1A.259 Drug-induced chronic gout, unspecified hip

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Hip

Summary

Drug-induced chronic gout, unspecified hip is a form of arthritis affecting the hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Formation of tophi (hard, painless lumps) around the hip joint
• Stiffness and limited range of motion in the hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis may detect urate crystals. Imaging such as X-rays or ultrasound can reveal joint damage or tophi. The unspecified hip designation indicates the affected side is not documented.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications like urate-lowering agents (e.g., allopurinol) are used long-term. Anti-inflammatory drugs (NSAIDs, colchicine) address acute flares. Lifestyle modifications, including dietary changes and hydration, support management.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up monitors uric acid levels and treatment efficacy. Untreated cases risk progressive joint damage and complications.

Complications

• Chronic joint damage or deformity
• Tophi formation leading to functional impairment
• Increased risk of kidney stones or renal impairment
• Recurrent flare-ups affecting quality of life

Lifestyle & Prevention

• Avoid medications known to raise uric acid (when possible)
• Maintain a balanced diet low in purines
• Stay hydrated to support uric acid excretion
• Limit alcohol and sugary beverages
• Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek care if experiencing severe or persistent hip pain, swelling, or stiffness. Prompt evaluation is needed for sudden symptom worsening or signs of infection (e.g., fever, redness).

Tips for Medical Coders

Use M1A.259 for drug-induced chronic gout affecting the hip when the specific side (right/left) is not documented. Ensure documentation supports the chronic nature and drug-induced etiology. Verify no more specific hip site is indicated before applying this code.